ArticleBriefings in bioinformatics2025
Gated-GPS: enhancing protein-protein interaction site prediction with scalable learning and imbalance-aware optimization.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence catalyzes antimicrobial peptide design.Synthetic and systems biotechnology · 2027Review
- Predicting protein-protein interaction sites based on dynamic perception mechanism within a hierarchical E(n)-equivariant graph.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In protein-protein interaction site (PPIS) prediction, existing machine learning models struggle with small datasets, limiting their predictive accuracy for unseen proteins. Additionally, class imbalance in protein complexes, where binding residues constitute a small fraction of all residues, hinders model performance. To address these challenges, we constructed a training dataset 9$\times $ larger than previous benchmarks by filtering the latest protein-protein complex data, improving diversity and generalization. We propose Gated-GPS, a Graph Transformer model with a novel gating mechanism designed to effectively leverage this expanded dataset. Additionally, we integrate cross-entropy loss with Tversky Loss to adjust sensitivity to positive and negative samples, mitigating class imbalance by emphasizing underrepresented binding residues. Experimental results show that Gated-GPS outperforms state-of-the-art (SOTA) models across four test sets. Notably, on the UBTest dataset, designed to evaluate generalization on unbounded proteins, our method improves MCC and AUPRC by 18.5% and 21.4%, respectively, over the previous SOTA. In a case study of snake venom toxin-protein interactions, our model accurately identified interaction sites, demonstrating its potential for therapeutic design and advancing the understanding of complex protein interactions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.